NAUT Stock: Earnings, Dividends & Analyst Estimates

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $0.82 - $4.31

6.2 Year NAUT Performance Metrics:

Total Return (with DRIP): -86.4% (-27.51% CAGR)

Total Return (no DRIP): -86.4% (-27.51% CAGR)

Share Price: -86.4% (-27.51% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $1,360

Total Return $ (with DRIP): -$8,640

NAUT Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

NAUT Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for NAUT

Based on past 6.2-year performance, here are NAUT growth metrics:

Share price CAGR of -27.51%
Dividend CAGR of +0%

Using NAUT CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	NAUT (DRIP)	NAUT - No DRIP
Current Price	$1.42	$1.42
Start Shares	7,042.25	7,042.25
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	7,042.25	7,042.25
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$0.06	$1.42
Total Dividends	$0	$0
Final Value	$400	$10,000

Estimated Future Value + Dividends - NAUT

NOTE: Above numbers are our estimate based on NAUT's Dividend and Price CAGR over past 6.2 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Nautilus Biotechnology, Inc. (NAUT) had its IPO on , and is traded on NASDAQ stock exchange.

Nautilus Biotechnology, Inc. is a life sciences company focused on proteomics, the large-scale study of proteins and their functions. Nautilus Biotechnology develops a platform technology designed to quantify and analyze the human proteome with high resolution, combining instrumentation, consumables, software, and analysis tools into an integrated workflow. Its current products and systems support single-molecule protein analysis and multi-cycle proteome mapping, serving research-oriented markets in biotechnology, pharmaceuticals, and academic science. The company’s platform is intended to help scientists examine protein complexity more deeply, supporting applications in biomedical research, disease biology, and drug discovery. Headquartered in Seattle, Washington, with research and development operations in San Carlos, California, Nautilus Biotechnology operates as a development-stage company in the life sciences tools segment.

NAUT website: https://www.nautilus.bio